OPY vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

OPY

60.6
AI Score
VS
OPY Wins

HIVE

47.3
AI Score

Investment Advisor Scores

OPY

61score
Recommendation
HOLD

HIVE

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric OPY HIVE Winner
Forward P/E 10.8108 62.8931 OPY
PEG Ratio 12 0 Tie
Revenue Growth 24.1% 73.5% HIVE
Earnings Growth 24.6% -99.9% OPY
Tradestie Score 60.6/100 47.3/100 OPY
Profit Margin 6.0% -98.5% OPY
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

OPY 1M: -11.5% · 3M: -7.0% HIVE 1M: -42.1% · 3M: -34.1%

Current Technical Phase

OPY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 31

RSI (14): 30.9 · Price: $102.06

HIVE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.7%), weak momentum, RSI 24

RSI (14): 23.9 · Price: $1.95

Fundamentals Snapshot

Metric OPY HIVE
Market Cap — —
Forward P/E 10.8 -3.8
Trailing P/E 11.3 —
Revenue (TTM) — —
Revenue Growth 0.2% 0.7%
Gross Margin 0.9% 0.4%
Operating Margin 0.2% -0.6%
EPS 9.01 -1.32
Dividend Yield 0.01% —

Frequently Asked Questions

Based on our detailed analysis, OPY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.